Health ❯ Healthcare ❯ Clinical Trials

Vaccine Development

mRNA Vaccines mRNA Technology Butantan-DV Trials Dengue Vaccine Moderna Pediatric Vaccines RSV Vaccine Trial BPZE1 Vaccine Placebo-Controlled Trials Phase 1 Trials Patient Outcomes Takeda Biopharmaceuticals RNA Vaccines Ebola Vaccine Nexvax2 Dengue Vaccine Trials Efficacy and Safety Personalized Medicine KRAS Mutations Efficacy Studies Government-funded Trials E. coli Vaccines ELI-002 2P Oncology Childhood Cancer Vaccines Sudan Ebola Vaccine Phase 3 Trials Innovative Techniques QDENGA Vaccine Tau Protein Vaccines

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

A successful late‑stage readout may clear the way for regulatory filings while full efficacy numbers, survival data and manufacturing plans are still pending.

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

Floss-Based Vaccine Shows Promise in Mice and Human Gumline Test

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

New Blood Test Diagnoses Celiac Disease Without Forcing Gluten Intake